Moderna Rises, Abercrombie & Finch Drops, and Brown-Forman Gains on Better Than Feared Guidance

Stock Movers · Mar 4, 2026 · 3m

On this episode of Stock Movers: - Moderna (MRNA) shares rise after the company agreed to pay $950 million to settle litigation related to the delivery technology behind its Covid shot, removing a looming financial risk for the struggling vaccine maker. The company has settled all litigation worldwide with Arbutus Biopharma Corp. and Genevant Sciences GmbH over its existing and future vaccines, with no future royalties owed. - Abercrombie & Finch (ANF) drops after the apparel retailer’s forecast for first quarter net sales growth and profits trailed the consensus estimates. Fourth…